SCHEMBL13943232

SCHEMBL13943232

CC(=O)c1ccc2cccnc2c1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
LMNA P02545 3/20 0.50
KDM4E B2RXH2 3/20 0.50
MAPT P10636 3/20 0.50
CCR1 P32246 3/20 0.50
CCR5 P51681 3/20 0.50
CCR8 P51685 3/20 0.50
HTT P42858 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
GMNN O75496 1/20 0.50
TP53 P04637 1/20 0.50
HSP90AA1 P07900 1/20 0.50
MMP2 P08253 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
MMP9 P14780 1/20 0.50
ALOX15 P16050 1/20 0.50
TSHR P16473 1/20 0.50
NFKB1 P19838 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL644794 0.86 ALDH1A1 (0.68) ALDH1A1LMNAKDM4EMAPTCCR1
SCHEMBL11973430 0.83 LMNA (0.56) ALDH1A1LMNAKDM4EMAPTCCR1
SCHEMBL253460 0.83 ALDH1A1 (0.73) ALDH1A1EGLN1
SCHEMBL15445449 0.82 ALDH1A1 (0.50) ALDH1A1LMNAKDM4EMAPTCCR1
SCHEMBL3502575 0.82 KDM4E (0.56) ALDH1A1LMNAKDM4EHTTSMN1; SMN2
SCHEMBL14136247 0.81 ALDH1A1 (0.49) ALDH1A1LMNAKDM4EMAPTCCR1
SCHEMBL9983599 0.81 ALDH1A1 (0.49) ALDH1A1LMNAKDM4EMAPTCCR1
SCHEMBL30144797 0.80 PARP1 (0.68) ALDH1A1LMNAKDM4EMAPTCCR1
SCHEMBL2632726 0.80 PARP1 (0.68) ALDH1A1LMNAKDM4EMAPTCCR1
Phenanthroline SCHEMBL28097109 0.79 LMNA (0.73) ALDH1A1LMNAKDM4EMAPTCCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090029939-A1 Pre-organized tricyclic integrase inhibitor compounds GILEAD SCIENCES, INC. 2009-01-29 US disclosed
US-20080076738-A1 Phosphonate Analogs Of Hiv Integrase Inhibitor Compounds GILEAD SCIENCES, INC. 2008-03-27 US disclosed
US-7253180-B2 Pre-organized tricyclic integrase inhibitor compounds GILEAD SCIENCES, INC. (US) 2007-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029939-A1 Pre-organized tricyclic integrase inhibitor compounds MUS81, CDKL4, INTS6 ALDH1A1 1902/4885LMNA 17/4885KDM4E 1594/4885
US-20080076738-A1 Phosphonate Analogs Of Hiv Integrase Inhibitor Compounds TYMP, PNP, PIKFYVE ALDH1A1 2788/4885LMNA 2126/4885KDM4E 1618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.